2014年以前の論文リスト
- Okubo M et al. Serum apolipoprotein B-48 concentration is associated with a reduced estimated glomerular filtration rate and increased proteinuria.
J Atheroscler Thromb. 2014;21(9):974-82 - Masuda D et al. Reference interval for the apolipoprotein B-48 concentration in healthy Japanese individuals.
J Atheroscler Thromb. 2014;21(6):618-27 - Nakaoka H et al. Establishment of a novel murine model of ischemic cardiomyopathy with multiple diffuse coronary lesions.
PLoS One. 2013;8(8):e70755 - Kawase R et al. Deletion of progranulin exacerbates atherosclerosis in ApoE knockout mice.
Cardiovasc Res. 2013;100(1):125-33 - Yuasa-Kawase M et al. Patients with CD36 deficiency are associated with enhanced atherosclerotic cardiovascular diseases.
J Atheroscler Thromb. 2012;19(3):263-75 - Inagaki M et al. Effect of probucol on antioxidant properties of HDL in patients with heterozygous familial hypercholesterolemia.
J Atheroscler Thromb. 2012;19(7):643-56 - Yuasa-Kawase M et al. Apolipoprotein B-48 to triglyceride ratio is a novel and useful marker for detection of type III hyperlipidemia after antihyperlipidemic intervention.
J Atheroscler Thromb. 2012;19(9):862-71 - Hanada H et al. Establishment of chemiluminescence enzyme immunoassay for apolipoprotein B-48 and its clinical applications for evaluation of impaired chylomicron remnant metabolism.
Clin Chim Acta. 2012;413(1-2):160-5 - Masuda D et al. Correlation of fasting serum apolipoprotein B-48 with coronary artery disease prevalence.
Eur J Clin Invest. 2012;42(9):992-9 - Tsubakio-Yamamoto K et al. Serum adiponectin level is correlated with the size of HDL and LDL particles determined by high performance liquid chromatography.
Metabolism. 2012;61(12):1763-70 - Saga A et al. HMG-CoA reductase inhibitor augments the serum total cholesterol-lowering effect of human adipose tissue-derived multilineage progenitor cells in hyperlipidemic homozygous Watanabe rabbits.
Biochem Biophys Res Commun. 2011;412(1):50-4 - Nakatani K et al. Serum apolipoprotein B-48 levels are correlated with carotid intima-media thickness in subjects with normal serum triglyceride levels.
Atherosclerosis. 2011;218(1):226-32 - Okura H et al. HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins.
J Atheroscler Thromb. 2010;17(6):568-77 - Sandoval JC et al. Fenofibrate reduces postprandial hypertriglyceridemia in CD36 knockout mice.
J Atheroscler Thromb. 2010;17(6):610-8 - Masuda D et al. Chylomicron remnants are increased in the postprandial state in CD36 deficiency.
J Lipid Res. 2009;50(5):999-1011 - Yamashita S et al. Where are we with probucol: a new life for an old drug?
Atherosclerosis. 2009;207(1):16-23 - Tsubakio-Yamamoto K et al. Adiponectin prevents atherosclerosis by increasing cholesterol efflux from macrophages.
Biochem Biophys Res Commun. 2008;375(3):390-4 - Oku H et al. Adiponectin deficiency suppresses ABCA1 expression and ApoA-I synthesis in the liver.
FEBS Lett. 2007;581(26):5029-33
